Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial
However, research has examined its effects on appetite and cravings, and its one component of an FDA-approved weight-management medication (more on that later)
Data collected included basic demographic and social characteristics including age, race, ethnicity, marital status, level of education (classified as less than college, i.e., high or middle school
The PlexusDx Precision Peptide Genetic Test ($99 add-on in month two) identifies your genetic predispositions in appetite-control pathways, revealing whether semaglutide, tirzepatide, or a dual-compound protocol will likely work best for your biology
PlexusDx's microdose GLP-1 protocol ($129/mo flat) introduces patients to the GLP-1 class with a gentler initiation, reducing nausea and gastrointestinal adaptation time
& Alaee, S